{
    "SPADE_N_14771": {
        "Sequence Information": {
            "Peptide Name": "Dermaseptin-PS4, Der-PS4",
            "Sequence": "ALWKTLLKHVGKAAGKAALNAVTDMVNQ",
            "Sequence Length": 28,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Antifungal",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "1. Phyllomedusa sauvagii",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "A0A5C0B7V8",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/A0A5C0B7V8",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Evaluating the Bioactivity of a Novel Antimicrobial and Anticancer Peptide, Dermaseptin-PS4(Der-PS4), from the Skin Secretion of Phyllomedusa sauvagii.",
                    "Pubmed ID": "31426323",
                    "Reference": "Molecules. 2019;24:E2974.",
                    "Author": "Chen D, Zhou X, Chen X, Huang L, Xi X, Ma C, Zhou M, Wang L, Chen T",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/31426323"
                }
            ],
            "Mass": 2949.47,
            "PI": 10.0,
            "Net Charge": 4,
            "Hydrophobicity": 0.16,
            "Frequent Amino Acids": "AKL",
            "Absent Amino Acids": "CEFIOPRSUY",
            "Basic Residues": 5,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 14,
            "Polar Residues": 14,
            "Positive Residues": 5,
            "Negative Residues": 1,
            "SPADE ID": "SPADE_N_14771",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_18938",
                    "Similarity": 1.0,
                    "Sequence": "ALWKTLLKHVGKAAGKAALNAVTDMVNQ"
                },
                {
                    "SPADE_ID": "SPADE_N_01172",
                    "Similarity": 0.9642857142857143,
                    "Sequence": "ALWKTLLKNVGKAAGKAALNAVTDMVNQ"
                },
                {
                    "SPADE_ID": "SPADE_N_06874",
                    "Similarity": 0.9285714285714286,
                    "Sequence": "ALWKSLLKNVGKAAGKAALNAVTDMVNQ"
                }
            ],
            "Hemolytic Activity": "Human microvascular endothelial cells HMEC-1:50% Cell death=460 µM,Horse erythrocytes:8% Hemolysis=32 µM,Horse erythrocytes:18% Hemolysis=64 µM,Horse erythrocytes:50% Hemolysis=128 µM",
            "Target Organism": "Staphylococcus aureus NCTC 10788(MIC=4µM),Staphylococcus aureus NCTC 12493(MIC=8µM),Enterococcus faecalis NCTC 12697(MIC=32µM),Escherichia coli NCTC 10418(MIC=8µM),Pseudomonas aeruginosa ATCC 27853(MIC=16µM),Candida albicans NCYC 1467(MIC=4µM),Staphylococcus aureus NCTC 10788(MBC=8µM),Staphylococcus aureus NCTC 12493(MBC=16µM),Enterococcus faecalis NCTC 12697(MBC=32µM),Escherichia coli NCTC 10418(MBC=16µM),Pseudomonas aeruginosa ATCC 27853(MBC=32µM),Candida albicans NCYC 1467(MFC=16µM),Human glioblastoma U251-MG(IC50=0.05766µM),Human squamous lung carcinoma NCI-H157(IC50=0.19µM),Human breast adenocarcinoma MDA-MB-435S(MIC=0.11µM),Human breast adenocarcinoma MCF-7(IC50=0.67µM),Human prostate adenocarcinoma PC-3(IC50=0.44µM)"
        }
    }
}